Last reviewed · How we verify
Pharyngal® Oromucosal Spray
Pharyngal Oromucosal Spray is a local anesthetic used to relieve pain in the throat.
Pharyngal Oromucosal Spray is a local anesthetic used to relieve pain in the throat. Used for Relief of pain in the throat.
At a glance
| Generic name | Pharyngal® Oromucosal Spray |
|---|---|
| Sponsor | Bosnalijek D.D |
| Drug class | Local anesthetic |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | Phase 3 |
Mechanism of action
It works by blocking the production of pain-causing chemicals in the nerves of the throat. This provides temporary relief from pain associated with sore throats, tonsillitis, and other conditions. The exact molecular target is not well-documented.
Approved indications
- Relief of pain in the throat
Common side effects
- Burning sensation
- Taste alteration
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Pharyngal® Oromucosal Spray CI brief — competitive landscape report
- Pharyngal® Oromucosal Spray updates RSS · CI watch RSS
- Bosnalijek D.D portfolio CI